ask="N/A"
ask_size="N/A"
average_daily_volume="20200"
bid="N/A"
bid_size="N/A"
book_value="0.44"
change="-0.10"
change_from_200_day_moving_average="-0.01"
change_from_50_day_moving_average="-1.12"
change_from_52_week_high="-2.80"
change_From_52_week_low="2.30"
change_in_percent="-1.90%"
close="5.15"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.46"
ebitda="-11.23M"
eps_estimate_current_year="-0.42"
eps_estimate_next_quarter="-0.16"
eps_estimate_next_year="-0.50"
ex_dividend_date="N/A"
float_shares="3301000"
high="5.22"
high_52_weeks="7.95"
last_trade_date="2/10/2017"
last_trade_price="5.15"
last_trade_size="100"
last_trade_time="4:00pm"
low="5.10"
low_52_weeks="2.85"
market_capitalization="147.85M"
moving_average_200_day="5.16"
moving_average_50_day="6.27"
name="OncoCyte Corporation Common Sto"
notes="N/A"
one_year_target_price="9.67"
open="5.17"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-0.13%"
percent_change_from_50_day_moving_average="-17.86%"
percent_change_from_52_week_high="-35.22%"
percent_change_from_52_week_low="+80.70%"
previous_close="5.25"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="11.88"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="28709000"
short_ratio="4.08"
stock_exchange="ASE"
symbol="OCX"
volume="11346"
weeks_range_52="2.85 - 7.95"
